Skip to content
Congress·In Committee·3 months ago

Congress Proposes Medicare Coverage for New Blood Tests to Detect Early Alzheimer's

Also known as: ASAP Act

Legislative Progress

✓ Filed
Review
House
Senate
President

Impact Analysis

Scores: 1 = low, 5 = highSentiment: -5 to +5 (net benefit)

Key Points

  • This bill would require Medicare to pay for new types of blood tests that can find signs of Alzheimer’s disease and other forms of dementia. These tests are designed to catch the disease early, even before a person starts showing clear symptoms.
  • To be covered, the tests must be approved by the FDA. While the focus is on blood tests that look at genes and proteins, the government could also choose to cover similar tests that use urine samples or medical imaging.
  • The goal is to help doctors find brain diseases sooner so patients can start treatments or make plans earlier. Currently, many dementia tests can be expensive or hard to get, and this change would make them more available to seniors.
  • If passed, Medicare would start paying for these screenings on January 1, 2028. This gives the government and health care providers time to set up the rules for how the tests will be used and paid for.
Healthcare

Milestones

2 milestones2 actions
Nov 19, 2025House

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Nov 19, 2025

Introduced in House

What Happens Next

Projected impacts based on AI analysis

2028-01-01

Medicare begins covering FDA-approved blood-based dementia screening tests

Seniors on Medicare could get blood tests to detect early signs of Alzheimer's without paying the full cost themselves, making early detection much more accessible.

Related News

5 articles
Washington Examiner·24 days ago

It’s time for bold action on neurodegenerative diseases

The article advocates for the bipartisan Alzheimer's Screening and Prevention (ASAP) Act, noting it would create a pathway for Medicare to cover FDA-approved blood-based tests for early dementia detection, empowering personal choice and responsibility in brain health.

CR+
Floridian Press·3 months ago

Vern Buchanan Pushes 'ASAP Act' Expanding Alzheimer's Screening

Florida Congressman Vern Buchanan and Rep. Paul Tonko introduced the ASAP Act to ensure seniors have timely access to innovative diagnostic tests. The bill aims to modernize Medicare's process for covering FDA-approved blood-based tests for early Alzheimer's detection.

C=
Health Policy Today·3 months ago

ASAP Act Would Expand Alzheimer's Detection

The Alzheimer's Screening and Prevention Act (ASAP) reflects growing recognition that early detection is essential. The bill would empower the HHS Secretary to give Medicare beneficiaries access to FDA-cleared biomarker tests, removing current legislative barriers to preventive services.

C+

Source Information

Document Type

Congressional Bill

Official Title

ASAP Act

Bill NumberHR 6130
Congress119th Congress
ChamberHouse of Representatives
Latest ActionReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsor

Cosponsors

(38)
D: 23R: 15

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.